🌍·1d agoResearch
Real-world drug survival and treatment outcome of ixekizumab in patients with spondyloarthropathies
Publisher
E
Europe PMC
EU
This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Europe PMC
- Region
- EU
- Scope
- Research
- Published
- September 22, 2026
- Language
- EN
Publisher context, original article off-platform
This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.
Source route
Continue on europepmc.org
Leave the platform to read the original full article on the publisher site.
Source: Europe PMC
Scope: Research
Related coverage
More related coverage
Crossref/15h ago
Peer Review Report For: Impact of Pharmacist Involvement in Antimicrobial Stewardship Programs on Clinical Outcome and Antibiotic Utilization in Intensive Care Unit: A Systematic Review and Meta-Analysis [version 1; peer review: 1 not approved]
Crossref/15h ago
Neck Disability, Associated Factors, and Quality of Life Among Physiotherapists in Saudi Arabia
Crossref/15h ago
Postoperative C-Reactive Protein as a Marker of the Early Inflammatory Response in Robotic Versus Laparoscopic Minimally Invasive Surgery for Endometrial Cancer: A Propensity Score-Matched Analysis
Crossref/15h ago